Progress and challenges in the clinical evaluation of immune responses to respiratory mucosal vaccines

Author:

Zhang Xuanxuan1,Zhang Jialu2,Chen Si3,He Qian1,Bai Yu1,Liu Jianyang1,Wang Zhongfang3,Liang Zhenglun1,Chen Ling34,Mao Qunying1,Xu Miao1

Affiliation:

1. State Key Laboratory of Drug Regulatory Science, Institute of Biological Products, National Institutes for Food and Drug Control, Beijing, China

2. National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun, China

3. Drug and Vaccine Research Center, Guangzhou National Laboratory, Guangzhou, China

4. State Key Laboratory of Respiratory Disease, Guangdong Laboratory of Computational Biomedicine, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China

Funder

Guangzhou National Laboratory

Publisher

Informa UK Limited

Reference88 articles.

1. Rethinking next-generation vaccines for coronaviruses, influenzaviruses, and other respiratory viruses

2. Timeline: WHO’s COVID-19 response; WHO; 2024 Jan 24 [cited 2024 Jan 24]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/interactive-timeline.

3. 2009 H1N1 Influenza

4. Confirmed death cases of COVID-19; WHO; 2024 Jan 24 [cited 2024 Jan 24]. Available from: https://covid19.who.int/.

5. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3